SCHEMBL8388013

SCHEMBL8388013

C=CCOC(=O)Cc1ccc2ccn(Cc3ccccc3)c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC8 Q9BY41 4/20 0.48
▸ BACE1 P56817 2/20 0.47
▸ APP P05067 4/20 0.46
▸ SNCA P37840 3/20 0.46
▸ HTR6 P50406 2/20 0.44
▸ BRD4 O60885 2/20 0.43
▸ HDAC1 Q13547 3/20 0.41
▸ HDAC2 Q92769 3/20 0.41
▸ HDAC10 Q969S8 3/20 0.41
▸ HDAC6 Q9UBN7 3/20 0.41
▸ HDAC9 Q9UKV0 3/20 0.41
▸ HDAC3 O15379 2/20 0.41
▸ HDAC4 P56524 2/20 0.41
▸ HDAC7 Q8WUI4 2/20 0.41
▸ HDAC11 Q96DB2 2/20 0.41
▸ HDAC5 Q9UQL6 2/20 0.41
▸ NCOR2 Q9Y618 1/20 0.41
▸ EPHX2 P34913 1/20 0.40
▸ NR1H4 Q96RI1 1/20 0.40
▸ FGFR1 P11362 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27475773 0.82 HDAC8 (0.62) HDAC8BACE1APPSNCAHTR6
SCHEMBL8387427 0.81 TSHR (0.48) HDAC8HDAC1HDAC2HDAC10HDAC6
SCHEMBL8387304 0.80 HDAC8 (0.55) HDAC8BACE1APPSNCAHTR6
SCHEMBL9057255 0.79 MTNR1A (0.41) CYP3A4
SCHEMBL8389114 0.78 APP (0.45) HDAC8BACE1APPSNCAHTR6
SCHEMBL9371461 0.78 HDAC8 (0.53) HDAC8BACE1APPSNCAHTR6
SCHEMBL203679 0.75 ALDH1A1 (0.61) CYP3A4
SCHEMBL6188765 0.75 ALDH1A1 (0.59) HDAC8HTR6HDAC1HDAC2HDAC10
SCHEMBL9055984 0.75 BACE1 (0.51) HDAC8BACE1APPSNCAHTR6
SCHEMBL11976844 0.74 HTR6 (0.56) HDAC8BACE1APPSNCAHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5877199-A ALZHEIMER'S DISEASE; SEDATIVE SANKYO COMPANY, LIMITED (JP) 1999-03-02 — — US disclosed
CN-1166169-A Heterocyclic compounds, useful as allosteric effectors at muscarinic receptors SANKYO CO (JP) 1997-11-26 — — CN disclosed
EP-0804416-A1 HETEROCYCLIC COMPOUNDS, USEFUL AS ALLOSTERIC EFFECTORS AT MUSCARINIC RECEPTORS SANKYO COMPANY LIMITED (JP) 1997-11-05 — — EP disclosed
WO-1996003377-A1 HETEROCYCLIC COMPOUNDS, USEFUL AS ALLOSTERIC EFFECTORS AT MUSCARINIC RECEPTORS SANKYO COMPANY, LIMITED (JP) 1996-02-08 — — WO disclosed
Send feedback